Nigeria: GSK Exits Nigeria After 51 Years of Operations

Pixabay
(file photo).
4 August 2023
Daily Trust (Abuja)
By Abiodun Alade

British multinational pharmaceutical and biotechnology company, GlaxoSmithKline (GSK), has announced plans to shut its operations in Nigeria.

Owing to increased competition from local companies and imports from India and China, GSK Nigeria saw its half-year sales drop to N7.75 billion from N14.8bn in the same period a year ago.

GSK Nigeria, which disclosed its decision, yesterday, in its filing with the Nigerian Exchange Limited, signed by the Company Secretary, Frederick Ichekwai, added that its parent company, GSK Plc UK, had revealed its intent to cease commercialisation of its prescription medicines and vaccines through its Nigerian subsidiary.

"In our published Q2 results we disclosed that the GSK UK Group has informed GlaxoSmithKline Consumer Nigeria PLC of its strategic intent to cease commercialization of its prescription medicines and vaccines in Nigeria through the GSK local operating companies and transition to a third-party direct distribution model for its pharmaceutical products," it said.

GlaxoSmithKline Consumer Nigeria Plc was incorporated in Nigeria in 1971 and commenced business in 1972, under the name Beecham Limited.

Read the original article on Daily Trust.

Tagged:
Copyright © 2023 Daily Trust. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.